Suchergebnisse - "Tashakori-Miyanroudi, Mahsa"

PubPharm (13)

1

Economic evaluation of ferric carboxymaltose compared with placebo in iron-deficient patients with heart failure : a systematic review

enthalten in: International journal of clinical pharmacy | 2023

von Rezapour, A. | Souresrafil, A. | Shamsaei, M. | +3

2

Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19 : a systematic review

enthalten in: Infectious diseases of poverty | 2023

von Rezapour, A. | Behroozi, Z. | Nasirzadeh, M. | +5

3

Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review

enthalten in: Infectious diseases of poverty | 2023

von Rezapour, A. | Behroozi, Z. | Nasirzadeh, M. | +5

4

Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review

enthalten in: Infectious diseases of poverty | 2023

von Rezapour, A. | Behroozi, Z. | Nasirzadeh, M. | +5

5

Cost Effectiveness of Adding Dapagliflozin to Standard Care in Heart Failure Patients with Reduced Ejection Fraction : A Systematic Review

enthalten in: American journal of cardiovascular drugs : drugs, devices, and other interventions | 2023

von Rezapour, A. | Tashakori-Miyanroudi, M. | Haghjoo, M. | +6

6

Economic evaluation of ferric carboxymaltose compared with placebo in iron-deficient patients with heart failure: a systematic review

enthalten in: International journal of clinical pharmacy | 2023

von Rezapour, A. | Souresrafil, A. | Shamsaei, M. | +3

7

Economic evaluation of ferric carboxymaltose compared with placebo in iron-deficient patients with heart failure: a systematic review

enthalten in: International journal of clinical pharmacy | 2023

von Rezapour, A. | Souresrafil, A. | Shamsaei, M. | +3

8

Economic evaluation of ferric carboxymaltose compared with placebo in iron-deficient patients with heart failure: a systematic review

enthalten in: Pharmacy world & science | 2023

von Rezapour, A. | Souresrafil, A. | Shamsaei, M. | +3

9

Cost Effectiveness of Adding Dapagliflozin to Standard Care in Heart Failure Patients with Reduced Ejection Fraction: A Systematic Review

enthalten in: American journal of cardiovascular drugs | 2023

von Rezapour, A. | Tashakori-Miyanroudi, M. | Haghjoo, M. | +6

10

Will carbon nanotube/nanofiber bring new hope for the treatment of heart damage? A systematic review

enthalten in: Nanomedicine | 2023

von Tashakori-Miyanroudi, M. | Janzadeh, A. | Seifalian, A. | +3